The prize amounts to up to $20 million, depending on the availability of finds.
The competition is part of HHS’ National Action Plan for Combating Antibiotic-Resistant Bacteria, which was released in March. The competition is sponsored by the National Institutes of Health and the Biomedical Advanced Research and Development Authority.
ASM will host a public consultation regarding the competition Oct. 7 in San Diego. Those interested in submitting written comments may do so through the challenges.gov website from Oct. 1 to Oct. 6.
More articles on diagnostics:
C. diff is over diagnosed by popular molecular tests, study finds
Physician misdiagnoses gain bigger spotlight as a patient safety issue
11 medical societies, healthcare organizations that form the Coalition to Improve Diagnosis